Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | IDO1 | P14902 | 3/20 | 0.30 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1552319 | 1.00 | KCNH2 (0.33) | KCNH2LMNAMAPTIDO1ROCK1 | |
| SCHEMBL1551863 | 1.00 | KCNH2 (0.33) | KCNH2LMNAMAPTIDO1ROCK1 | |
| SCHEMBL1552530 | 0.89 | HTR1A (0.34) | LMNAMAPTKDM4ENPC1ALOX15 | |
| SCHEMBL1552303 | 0.89 | HTR1A (0.34) | LMNAMAPTKDM4ENPC1ALOX15 | |
| SCHEMBL1552292 | 0.89 | HTR1A (0.34) | LMNAMAPTKDM4ENPC1ALOX15 | |
| SCHEMBL1552567 | 0.85 | TSHR (0.35) | LMNAMAPTTSHR | |
| SCHEMBL1551812 | 0.85 | TSHR (0.35) | LMNAMAPTTSHR | |
| SCHEMBL1552565 | 0.85 | TSHR (0.35) | LMNAMAPTTSHR | |
| SCHEMBL1552278 | 0.85 | TSHR (0.35) | LMNAMAPTTSHR | |
| SCHEMBL5442927 | 0.85 | TSHR (0.35) | LMNAMAPTTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2012588-B1 | AQUEOUS SUSPENSION CONCENTRATE | BAYER CROPSCIENCE AG (DE) | 2011-04-27 | — | — | EP | disclosed |
| EP-1958509-A1 | Herbicide combination | Bayer CropScience AG (DE) | 2008-08-20 | — | — | EP | disclosed |
| EP-1854355-A1 | Aqueous suspension concentrates | Bayer CropScience AG (DE) | 2007-11-14 | — | — | EP | disclosed |
| US-20070219095-A1 | AQUEOUS SUSPENSION CONCENTRATES | BAYER CROPSCIENCE GMBH (DE) | 2007-09-20 | — | — | US | disclosed |
| EP-1790227-A1 | Aqueous suspension-concentrates of 2,4-diamino-s-triazine herbicides | Bayer CropScience AG (DE) | 2007-05-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070219095-A1 | AQUEOUS SUSPENSION CONCENTRATES | SLC43A1, AS3MT, SLC7A5 | KCNH2 4039/4885LMNA 4673/4885MAPT 1576/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.